ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Aethlon Medical (AEMD)
Aethlon Medical stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
$5.22▲ +1.36%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
39%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Aethlon Medical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Aethlon Medical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Aethlon Medical a 39% chance of finishing higher a month from now (21 trading sessions) than today: somewhat worse than a coin flip.
In half of the simulated outcomes the price ends between $3.38 and $6.25; in 9 out of 10, between $1.95 and $10.80. Estimated annual volatility is 200%.
Key numbers
- Market cap
- $4.6M
- Revenue (12 months)
- $0.0M
- Return on equity
- -160.9%
- Free cash flow (12 months)
- $-4.8M
- Beta
- 1.40
What this means
ATLAS does not publish a fair value for AEMD right now, but it does show its odds of rising: somewhat worse than a coin flip.
Its beta is 1.40: it tends to move more than the market, both up and down.
About the company
Aethlon Medical, Inc. is a medical therapeutic company focused on developing immunotherapeutic technologies for oncology and infectious disease.
Want to see everything about Aethlon Medical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Aethlon Medical do?
Aethlon Medical, Inc. is a medical therapeutic company focused on developing immunotherapeutic technologies for oncology and infectious disease.
What is the chance AEMD goes up next month?
39%: somewhat worse than a coin flip. In half of the simulated outcomes, AEMD ends the month between $3.38 and $6.25.
How big is Aethlon Medical and what is its P/E ratio?
Aethlon Medical's market capitalization is $4.6M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is AEMD?
ATLAS estimates annual volatility at 200%. In a typical month, half of the outcomes end between $3.38 and $6.25.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer